OncoAlert OncoAlert

Dear Colleagues,Welcome to this Hematology Round Up from hashtag#ASCO24 . WE have focused on Hematologic malignancies with 3 presentations which were presented on June 2nd, 2024The first presentation was the Phase 3 study results of isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) versus VRd for transplant-ineligible patients with newly diagnosed multiple myeloma (IMROZ) . Presented by Dr. FaconThis trial presentation came with a concomitant publication on the New Englan...

✅ TheLancet Commission on #ProstateCancer ✅DESTINY-PanTumor01✅Osimertinib+Local tx for brain🧠mets in EGFRm #NSCLC 🫁✅ASCENT in Triple Negative #BreastCancer 🧪✅Bilateral Oophorectomy in BRCA1&2🧬✅Racialized inequities in live birth after cancer🤰🏾✅MITO END in Endometrial Cancer✅Tx Patterns Advanced Urothelial Carcinoma🇺🇸and more‼️

The OncoAlert Weekly Round Up 🚨Covering April 26- May 1st, 2024REGISTER at http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registration COVERINGDESTINY-Breast06Monarch E US Preventive S Task force #BreastCancer Screen @US_FDA approval of Tisotumab vedotinNEO predict-LungPushing Boundaries in ctDNAStereotactiveRT in oligomet #KidneyCancerThromboembolic Risk in #ProstateCancer Patients Treated with PARP Inhibitors @CancerCareMASCC - @ASCO Standards a...

What happens when Five Friends initially brought together by oncology meet up in Lugano for #APCCC24..........Magic...thats what!Join Renu, Declan, Brian, Tom and Gil on this insanely casual and fun conversation on the side

The OncoAlert Weekly Round UpCovering April 19-25, 2024REGISTER AT http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/oncoalert-newsletter-registrationDiscussingADCs in #LungCancer & #BreastCancer Out on @Annals_Oncologyhttps://annalsofoncology.org/article/S0923-7534(24)00108-X/abstractTILS in #TNBChttps://jamanetwork.com/journals/jama/article-abstract/2816923TROPION in #BreastCancerhttps://ascopubs.org/doi/full/10.1200/JCO.23.01909DE-REAL in #BreastCancer htt...

✅Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma out on @NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2312695#ap0✅Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial https://www.annalsofoncology.org/article/S0923-7534(24)00105-4/fulltext✅Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrumhttps://www.cell.com/cell-re...